Cp2Zr(13CH3)2
(1) has been used as a probe for the reactivity of
metallocene−methylaluminoxane catalysts for olefin polymerization. A 1H and
13C NMR study of the reaction equilibria
between
Cp2Zr(13CH3)2
and Lewis acids such as AlMe3 (2),
B(C6F5)3 (3), and
methylaluminoxane (MAO) (4) has
been performed. AlMe3 is always present in MAO
solutions, and B(C6F5)3 is a
relatively strong Lewis
acid, which has a capacity to form and stabilize ion pairs comparable
to that of MAO. The use of
isotopically 13C-enriched dimethylzirconocene has permitted
the study of these systems by 13C NMR in
conditions as close as possible to usual polymerization conditions,
which require large excesses of MAO
for reaching high activities. The comparisons of the reactivity of
Cp2Zr(13CH3)2
with B(C6F5)3 and with
MAO have provided the first direct evidence of the formation in
solution of monomeric [Cp2Zr(13CH3)]+[Me·MAO]-
(8), of dimeric
[Cp2Zr(13CH3)]2(μ-13CH3)+[Me·MAO]-
(7), and of the
[(Cp2Zr(μ-Me)2AlMe2]+[Me·MAO]-
(9) cationic species, having MeMAO-
counterions. The influence of temperature,
Al/Zr mole ratio, and zirconium concentration on the equilibria of ion
pair formation has been elucidated.
In concentrated suspensions, stratification occurs in experiments only for the higher size ratio α = 7. Simulations using a high Péclet number, additionally find stratification with α = 2, when ϕ is high enough. Our results provide a quantitative understanding of the conditions under which stratified colloidal films assemble. Our research has relevance for the design of coatings with targeted optical and mechanical properties at their surface.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.